Apoptosis Inhibitor of Macrophage and Acute Inflammation in IgA Nephropathy

BACKGROUND: IgA nephropathy is characterized by mesangial deposits of IgA1-containing immune complex with complement 3 (C3). Our previous study demonstrated that apoptosis inhibitor of macrophage (AIM) plays a critical role in in situ IgA-containing immune complex formation and subsequent complement activation in murine IgA nephropathy. We further evaluated the clinicopathological role of AIM in human IgA nephropathy. METHODS: We enrolled 77 patients with IgA nephropathy, 5 patients with thin basement membrane disease as disease controls, and 40 age-matched healthy individuals as healthy controls. We analyzed the association between serum IgM-free AIM (sAIM)/glomerular AIM (gAIM) deposition area and clinicopathological features. RESULTS: sAIM level was higher in patients with IgA nephropathy at diagnosis than in disease and healthy controls (1.02 ± 0.49 µg/mL vs. 0.56 ± 0.19 µg/mL vs. 0.57 ± 0.20 µg/mL), significantly decreased to 0.67 ± 0.44 µg/mL after tonsillectomy and steroid pulse therapy, and was associated with serum IgA (r2 = 0.23) and IgA-IgG immune complex levels (r2 = 0.12). gAIM was colocalized with mesangial IgA and high intensity of gAIM was associated with the degree of hematuria (30-49/HPF vs. 10-19/HPF) and acute lesions, including those with Oxford classification scores of endocapillary hypercellularity (E1 3% vs. E0 2%) and crescent formation (C1 3% vs. C0 2%). Furthermore, gAIM deposition was positively correlated with glomerular C3 deposition (r2 = 0.54). Multivariate Cox regression analysis revealed sAIM as independent predictor of hematuria remission (HR = 1.86, 95% CI= 1.03-3.15). According to Kaplan-Meier analysis, patients with larger reduction of sAIM (≥ 0.45 µg/mL) following tonsillectomy and steroid pulse therapy showed a significantly improved hematuria (6 vs. 9 months). CONCLUSIONS: We suggest that IgA nephropathy patients with high sAIM levels have high disease activity and patients with high intensity of gAIM deposition have acute glomerular injuries leading to hematuria.

Authors

Institutions

Publication Details

Journal
Kidney360
Published
2026-05-22
DOI
https://doi.org/10.34067/kid.0000001202
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Apoptosis Inhibitor of Macrophage and Acute Inflammation in IgA Nephropathy

Toru Miyazaki, Satoko Arai, Yuko Makita, Maiko Nakayama et al.
Kidney360
Renal Diseases and Glomerulopathies
article

Apoptosis Inhibitor of Macrophage and Acute Inflammation in IgA Nephropathy

Toru Miyazaki, Satoko Arai, Yuko Makita, Maiko Nakayama, Ayako Koizumi, Yusuke Fukao, Rina Kato, Keisuke Yasuda, Toshiki Kano, Y Suzuki, Yoshihito Nihei, Ryosuke Aoki, Hitoshi Suzuki, Masahiro Muto
article en

Abstract

BACKGROUND: IgA nephropathy is characterized by mesangial deposits of IgA1-containing immune complex with complement 3 (C3). Our previous study demonstrated that apoptosis inhibitor of macrophage (AIM) plays a critical role in in situ IgA-containing immune complex formation and subsequent complement activation in murine IgA nephropathy. We further evaluated the clinicopathological role of AIM in human IgA nephropathy. METHODS: We enrolled 77 patients with IgA nephropathy, 5 patients with thin basement membrane disease as disease controls, and 40 age-matched healthy individuals as healthy controls. We analyzed the association between serum IgM-free AIM (sAIM)/glomerular AIM (gAIM) deposition area and clinicopathological features. RESULTS: sAIM level was higher in patients with IgA nephropathy at diagnosis than in disease and healthy controls (1.02 ± 0.49 µg/mL vs. 0.56 ± 0.19 µg/mL vs. 0.57 ± 0.20 µg/mL), significantly decreased to 0.67 ± 0.44 µg/mL after tonsillectomy and steroid pulse therapy, and was associated with serum IgA (r2 = 0.23) and IgA-IgG immune complex levels (r2 = 0.12). gAIM was colocalized with mesangial IgA and high intensity of gAIM was associated with the degree of hematuria (30-49/HPF vs. 10-19/HPF) and acute lesions, including those with Oxford classification scores of endocapillary hypercellularity (E1 3% vs. E0 2%) and crescent formation (C1 3% vs. C0 2%). Furthermore, gAIM deposition was positively correlated with glomerular C3 deposition (r2 = 0.54). Multivariate Cox regression analysis revealed sAIM as independent predictor of hematuria remission (HR = 1.86, 95% CI= 1.03-3.15). According to Kaplan-Meier analysis, patients with larger reduction of sAIM (≥ 0.45 µg/mL) following tonsillectomy and steroid pulse therapy showed a significantly improved hematuria (6 vs. 9 months). CONCLUSIONS: We suggest that IgA nephropathy patients with high sAIM levels have high disease activity and patients with high intensity of gAIM deposition have acute glomerular injuries leading to hematuria.

Kidney360
Juntendo University (JP)
Good health and well-being
Openalex Percentile: Top 5%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.